Peptides stocked at nexaph peptides
30 peptides currently tracked
Neuroprotective octapeptide from ADNP researched for microtubule stabilization and cognitive preservation.
Synthetic analog of the growth-hormone 176–191 lipolytic region — developed by Metabolic Pharmaceuticals and the vers…
Synthetic 11-amino acid peptide derived from erythropoietin (EPO), researched for neuroprotection, tissue repair, and…
Synthetic 15-amino acid peptide derived from a gastric protein, researched for tissue repair, gut healing, tendon rec…
Long-acting amylin receptor agonist developed by Novo Nordisk, researched for appetite regulation and weight manageme…
Modified growth hormone-releasing hormone (GHRH) analog for pulsatile GH release. Also known as Mod GRF (1-29). Short…
Nine-amino acid neuropeptide researched for sleep regulation, stress adaptation, and normalization of disturbed sleep…
Synthetic tetrapeptide (Ala-Glu-Asp-Gly) researched for telomerase activation, telomere elongation, and potential ant…
Copper-binding tripeptide researched for skin regeneration, wound healing, collagen stimulation, and anti-aging effects.
Selective growth hormone secretagogue (GHS) that stimulates pulsatile GH release with minimal effects on cortisol and…
Anti-inflammatory tripeptide from α-MSH researched for gut health, skin barrier repair, and NF-κB inhibition.
The only human cathelicidin antimicrobial peptide with broad-spectrum activity against bacteria, viruses, and fungi.
Linear alpha-MSH analog (afamelanotide) approved in the EU as Scenesse® for erythropoietic protoporphyria. Researched…
Synthetic alpha-MSH analog researched for skin pigmentation (tanning), photoprotection, and sexual function enhancement.
Mitochondrial-derived peptide researched for metabolic regulation, exercise mimicry, insulin sensitivity, and longevity.
Acetylated/amidated Semax analog (Ac-MEHFPGP-NH₂). Longer half-life than plain Semax. Distinct compound, not an alias.
The arginine-salt form of BPC-157 — the same 15-amino-acid gastric pentadecapeptide (GEPPPGKPADDAGLV), marketed as a …
Melanocortin receptor agonist (bremelanotide) FDA-approved as Vyleesi® for hypoactive sexual desire disorder in preme…
Synthetic heptapeptide derived from tuftsin, researched for anxiolytic effects, immune modulation, and cognitive enha…
GLP-1 receptor agonist for blood sugar regulation and weight management. Sold as Ozempic®, Wegovy®, and Rybelsus®.
Synthetic heptapeptide derived from ACTH(4-10), researched for neuroprotection, cognitive enhancement, and brain inju…
Synthetic 29-amino acid GHRH analog, the first FDA-approved GH-releasing peptide (Geref®). Stimulates natural pulsati…
Synthetic octapeptide researched for reducing wrinkle depth by modulating SNARE complex formation, mimicking a topica…
Mitochondria-targeted tetrapeptide researched for restoring cellular energy production, reducing oxidative stress, an…
Dual GLP-1/glucagon receptor agonist developed by Boehringer Ingelheim, in Phase 3 trials for obesity and MASH (metab…
Synthetic fragment of Thymosin Beta-4 researched for tissue repair, inflammation reduction, wound healing, and cardia…
Synthetic growth hormone-releasing hormone (GHRH) analog, FDA-approved as Egrifta® for HIV-associated lipodystrophy. …
Thymic peptide researched for immune modulation, T-cell activation, and antiviral response. Approved in over 35 count…
28-amino-acid neuropeptide researched for immune regulation, neuroprotection, and circadian rhythm modulation.